| Immune | ECM | Hypoxia | Cell cycle | Citrate cycle | Degenerative diseases | # of genes |
---|
HDEGa | 125 | 269 | 164 | 239 | 74 | 159 | 888 |
DEb | 43 | 57 | 88 | 84 | 9 | 21 | 220 |
TSUc S > Md | 13 | 14 | 8 | 6 | 1 | 5 | 39 |
TSU M > Sd | 4 | 4 | 3 | 5 | – | 5 | 21 |
TPDe S < Mf | 4 | 7 | 14 | 9 | – | 4 | 36 |
TPD M < Sf | 4 | 9 | 6 | 6 | – | 5 | 27 |
- aHDEG highly differentially expressed genes |log2f| ≥2
- bDE Differentially Expressed—the number of HDEG refers to when the difference in the change between the species following the 3-MCA injection is |log2f| ≥1
- cTSU Tumor Suppressors Up-regulated
- dS > M, M > S: higher elevation in the Spalax compared to the mice, or the mice compared to the Spalax, respectively
- eTPD Tumor Promoters Down-regulated
- fS < M, M < S: stronger down-regulation in the Spalax compared to the mice, or the mice compared to Spalax, respectively